top of page
SPEAKER INFORMATION
Jon Beaman
MHRA
Jon is Deputy Director for Innovative Medicines licensing in Healthcare Quality and Access, Medicines and Healthcare products Regulatory Agency (MHRA). The group is responsible for marketing assessments for new active substances and biological products including monoclonal antibodies, gene and cell therapy products, blood products and vaccines. Prior to joining the MHRA in 2024, Jon spent 30 years in industry, most recently as Executive Director in pharmaceutical development.

bottom of page